XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.4
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - 7 months ended Dec. 31, 2022 - USD ($)
Total
Additional Paid-In Capital
Accumulated Deficit
Ordinary Shares
Balance, amount at Jun. 14, 2022 $ 0 $ 0 $ 0 $ 0
Founder shares issued to initial shareholder, shares       10,000
Founder shares issued to initial shareholder, amount 1 0 0 $ 1
Founder shares issued to initial shareholders shares       1,725,000
Founder shares issued to initial shareholders amount 25,000 24,827   $ 173
Founder shares surrendered shares       (10,000)
Founder shares surrendered amount (1) 0 0 $ (1)
Sale of public units through public offering shares       6,900,000
Sale of public units through public offering amount 69,000,000 68,999,310   $ 690
Sale of private placement units shares       385,750
Sale of private placement units amount 3,857,500 3,857,462   $ 38
Issuance of representative shares, shares       200,000
Issuance of representative shares, amount 1,046,000 1,045,980   $ 20
Share compensation expense 93,780 93,780    
Underwriters' discount (3,795,000) (3,795,000)    
Other offering expenses (1,627,124) (1,627,124)    
Reclassification of ordinary shares subject to redemption, shares       (6,900,000)
Reclassification of ordinary shares subject to redemption, amount (60,306,000) (60,305,310) 0 $ (690)
Allocation of offering costs to ordinary shares subject to redemption, amount 4,712,045 4,712,045    
Initial accretion of carrying value to redemption value (14,613,545) (13,005,970) (1,607,575)  
Subsequent accretion of carrying value to redemption value (13,351)   (13,351)  
Net loss (123,960)   (123,960)  
Balance, amount at Dec. 31, 2022 $ (1,744,655) $ 0 $ (1,744,886) $ 231
Balance, shares at Dec. 31, 2022 200,000     2,310,750